Kawase, K., Yoshida, K., Hara, K., Hidaka, S. and Takeyama, H. 2023. Efficacy and safety of neoadjuvant chemotherapy with dose de-escalation tri-weekly nanoparticle albumin-bound paclitaxel and FEC for human epidermal growth factor receptor 2-positive breast cancer. Clinical Medicine Insights. 4, 2 (Jun. 2023), 378–386. DOI:https://doi.org/10.52845/CMI/2023-4-2-1.